At Concemed, we have always believed that true innovation knows no borders. Today, we are proud to share a defining moment in our journey of internationalization: the first successful overseas installation of our independently developed V1000 video endoscope system at a premier high-end hospital in Busan, South Korea.

Entering the South Korean market is more than a commercial success; it is a rigorous validation of our technology. As a global hub for gastroenterology, South Korea is known for its exceptionally high clinical standards and a market long dominated by legacy international brands. By successfully integrating the V1000 into this high-barrier environment, we have demonstrated that our high-end equipment matches the world's best.

  Winning the "Doctor's Choice": Clinical Validation in Busan

The institution that chose the V1000 is a leading medical center in Busan, operating four specialized endoscopy suites. Historically, their department relied exclusively on top-tier global brands. Before partnering with us, they had tested various other systems but found them lacking in the imaging clarity and tactile feedback required for their high-volume clinical work.

During a comprehensive three-week clinical trial, our V1000 system earned the praise of the hospital’s Physician head. Key feedback highlighted:

Seamless Transition: The operation handle provides a level of smoothness and user logic consistent with existing premium systems, requiring zero adaptation time for the staff.

Reliability: Our integrated LED light source offers a lifespan exceeding 20,000 hours, effectively covering the device's entire lifecycle and eliminating the downtime and costs associated with traditional xenon lamp replacements.

  Looking Ahead: Our Commitment to Global Healthcare

This installation in South Korea is our "pilot" for the global stage. It signifies that Concemed has evolved from a manufacturer into a comprehensive system solution provider recognized within international clinical frameworks.

As we look to the future, we remain focused on clinical-driven globalization. We will continue to refine our imaging and intelligent diagnostic assistance, partnering with global experts to ensure that medical innovation delivers value to patients and providers worldwide.